An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

NCT00619866 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis, Pain

Interventions

DRUG: Elagolix
DRUG: placebo

Sponsor

AbbVie